Wedbush Downgrades Inozyme Pharma Inc. (INZY) to Neutral

May 16, 2025 9:24 AM EDT Send to a Friend
Wedbush analyst David Nierengarten downgraded Inozyme Pharma Inc. (NASDAQ: INZY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login